NCT02065323 2015-01-19A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADTComprehensive Cancer Centers of NevadaPhase 2 Withdrawn